Nuclear Medicine
DMSA
Name:
DMSA-Sn Radiofarma® TC
Active Principle:
Dimercap Succinic Acid
Therapeutic Action:
It is indicated for renal scintigraphy by means of static (planar or tomographic) and dynamic images of the kidney by scintigraphy; whether they are morphological studies of the renal cortex, function of the individual kidney or location of the ectopic kidney.
Nuclear Medicine
DMSA
Name:
DMSA-Sn Radiofarma® TC
Active Principle:
Dimercap Succinic Acid
Therapeutic Action:
It is indicated for renal scintigraphy by means of static (planar or tomographic) and dynamic images of the kidney by scintigraphy; whether they are morphological studies of the renal cortex, function of the individual kidney or location of the ectopic kidney.
RELATED PRODUCTS
-
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to...